Quick Summary

Mounjaro (tirzepatide) is an FDA-approved weight loss medication that targets both GLP-1 and GIP receptors. Weekly injections provide superior appetite suppression with average weight loss of 15-20% body weight. Available in Glasgow through registered pharmacist supervision.

What is Mounjaro?

Medical Review: Reviewed by registered pharmacist. Last Updated: December 2025. Location: Glasgow, Scotland.

Introduction to Mounjaro

Mounjaro is the brand name for tirzepatide, a prescription medication approved by the FDA for chronic weight management. It belongs to a class of medications called dual GIP and GLP-1 receptor agonists, making it unique among weight loss medications.

Our Glasgow clinic offers Mounjaro treatment under the supervision of a registered pharmacist. Learn more about Mounjaro treatment in Glasgow.

What Makes Mounjaro Different?

Mounjaro is unique because it targets two receptors simultaneously:

GLP-1 Receptor: Reduces appetite and slows digestion
GIP Receptor: Enhances insulin secretion and further reduces appetite

This dual-action mechanism may provide superior weight loss results compared to single-receptor medications like Wegovy. Compare: Mounjaro vs Wegovy.

How Mounjaro Works

Mounjaro works through several mechanisms to promote weight loss:

Appetite Reduction: Signals to your brain that you're full, reducing hunger
Slowed Digestion: Food stays in your stomach longer, increasing feelings of fullness
Blood Sugar Control: Helps maintain stable blood sugar levels, reducing cravings
Reduced Food Intake: Combined effects lead to eating less without feeling deprived

Learn more about how weight loss treatment works.

Mounjaro Dosage and Administration

Mounjaro is administered as a weekly injection under the skin (subcutaneous). Treatment typically starts at 2.5mg and gradually increases to a maintenance dose of 5mg, 10mg, or 15mg based on your response and tolerance.

Our pharmacist provides training on proper injection technique during your consultation. See our complete dosage guide and injection instructions.

Mounjaro Weight Loss Results

Clinical trials demonstrate impressive weight loss results with Mounjaro:

Average Weight Loss: 15-20% body weight over 72 weeks
Time to Results: Most patients see results within 4-8 weeks
Sustained Results: Weight loss maintained with continued treatment

View our expected weight loss timeline and week-by-week results guide.

Mounjaro Safety and Side Effects

Mounjaro is FDA-approved and considered safe when prescribed and monitored by a healthcare professional. Common side effects include nausea, vomiting, diarrhoea, and constipation, typically mild and temporary.

Learn more about Mounjaro safety and side effects.

Who Can Use Mounjaro?

Mounjaro is suitable for adults with:

BMI of 30 or higher (obesity)
BMI of 27 or higher with weight-related conditions (overweight)
No contraindications (thyroid cancer, severe GI disease, etc.)

Our pharmacist assesses your eligibility during consultation. Check your eligibility or use our BMI calculator.

Frequently Asked Questions

What is Mounjaro used for?

Mounjaro (tirzepatide) is FDA-approved for chronic weight management in adults with obesity or overweight with weight-related medical conditions.

How does Mounjaro work?

Mounjaro works by targeting both GLP-1 and GIP receptors, reducing appetite, slowing gastric emptying, and helping maintain stable blood sugar levels.

What is the active ingredient in Mounjaro?

The active ingredient is tirzepatide, a dual-action medication that mimics two natural hormones to reduce appetite and promote weight loss.

Is Mounjaro the same as Ozempic?

No, Mounjaro (tirzepatide) and Ozempic (semaglutide) are different medications. Mounjaro targets two receptors while Ozempic targets one, potentially making Mounjaro more effective for weight loss.

How is Mounjaro administered?

Mounjaro is administered as a weekly self-injection under the skin (subcutaneous). Our pharmacist provides training on proper injection technique.